IMMUNITYBIO, INC. (IBRX)
ImmunityBio to Present New Comparative Data, Scientific Advances in Non-Muscle Invasive Bladder Cancer CIS and an Update on BCG Naïve Registrational Trial at American Urological Association Annual Meeting
ImmunityBio to Present New Comparative Data, Scientific Advances in Non-Muscle Invasive Bladder Cancer CIS and an Update on BCG Naïve Registrational Trial at American Urological Association Annual Meeting
📈 **POSITIVE** • High confidence analysis (84%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business